

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 6.56333457 |
| 2 | muscle filament sliding (GO:0030049) | 6.56333457 |
| 3 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.43271914 |
| 4 | actin-mediated cell contraction (GO:0070252) | 5.31461287 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.18520587 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.14291844 |
| 7 | layer formation in cerebral cortex (GO:0021819) | 5.04926123 |
| 8 | vocalization behavior (GO:0071625) | 5.02551598 |
| 9 | locomotory exploration behavior (GO:0035641) | 4.96781143 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 4.96047467 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.91534884 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.80074594 |
| 13 | skeletal muscle contraction (GO:0003009) | 4.76977669 |
| 14 | regulation of synapse structural plasticity (GO:0051823) | 4.75510308 |
| 15 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.69947927 |
| 16 | regulation of relaxation of muscle (GO:1901077) | 4.67237167 |
| 17 | synaptic vesicle exocytosis (GO:0016079) | 4.61855184 |
| 18 | protein localization to synapse (GO:0035418) | 4.57944586 |
| 19 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.49116921 |
| 20 | exploration behavior (GO:0035640) | 4.45235066 |
| 21 | nucleobase catabolic process (GO:0046113) | 4.45186701 |
| 22 | regulation of skeletal muscle contraction (GO:0014819) | 4.42981311 |
| 23 | glutamate secretion (GO:0014047) | 4.37001621 |
| 24 | striated muscle contraction (GO:0006941) | 4.33477378 |
| 25 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.32587075 |
| 26 | dendritic spine morphogenesis (GO:0060997) | 4.19672228 |
| 27 | sarcomere organization (GO:0045214) | 4.14310525 |
| 28 | myofibril assembly (GO:0030239) | 4.06612273 |
| 29 | dendrite morphogenesis (GO:0048813) | 4.06291117 |
| 30 | neuron recognition (GO:0008038) | 4.05682358 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.03761334 |
| 32 | actin filament-based movement (GO:0030048) | 3.96850146 |
| 33 | postsynaptic membrane organization (GO:0001941) | 3.92552972 |
| 34 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.89491247 |
| 35 | axonal fasciculation (GO:0007413) | 3.88161625 |
| 36 | cell migration in hindbrain (GO:0021535) | 3.84645159 |
| 37 | regulation of synaptic vesicle transport (GO:1902803) | 3.81499530 |
| 38 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.81373278 |
| 39 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.76088259 |
| 40 | response to inactivity (GO:0014854) | 3.74436748 |
| 41 | neuromuscular synaptic transmission (GO:0007274) | 3.71953982 |
| 42 | positive regulation of synapse maturation (GO:0090129) | 3.71945215 |
| 43 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.69481504 |
| 44 | neurotransmitter secretion (GO:0007269) | 3.67992157 |
| 45 | auditory behavior (GO:0031223) | 3.64290346 |
| 46 | cardiac muscle contraction (GO:0060048) | 3.64069771 |
| 47 | activation of protein kinase A activity (GO:0034199) | 3.63447926 |
| 48 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.63426185 |
| 49 | proline transport (GO:0015824) | 3.60921189 |
| 50 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.58134563 |
| 51 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.56675219 |
| 52 | glutamate receptor signaling pathway (GO:0007215) | 3.54056069 |
| 53 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.52504109 |
| 54 | cardiac myofibril assembly (GO:0055003) | 3.49671027 |
| 55 | response to pheromone (GO:0019236) | 3.49619342 |
| 56 | mitochondrion transport along microtubule (GO:0047497) | 3.49279728 |
| 57 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.49279728 |
| 58 | regulation of actin filament-based movement (GO:1903115) | 3.46531243 |
| 59 | synaptic transmission, glutamatergic (GO:0035249) | 3.43270332 |
| 60 | negative regulation of microtubule polymerization (GO:0031115) | 3.42502952 |
| 61 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.40629139 |
| 62 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.40469488 |
| 63 | axon extension (GO:0048675) | 3.37570560 |
| 64 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.35791852 |
| 65 | muscle fiber development (GO:0048747) | 3.34526146 |
| 66 | establishment of mitochondrion localization (GO:0051654) | 3.33400870 |
| 67 | neuron-neuron synaptic transmission (GO:0007270) | 3.30755109 |
| 68 | skeletal muscle fiber development (GO:0048741) | 3.27362241 |
| 69 | presynaptic membrane assembly (GO:0097105) | 3.25988142 |
| 70 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.24739240 |
| 71 | regulation of membrane repolarization (GO:0060306) | 3.20938612 |
| 72 | gamma-aminobutyric acid transport (GO:0015812) | 3.20766687 |
| 73 | neuronal action potential propagation (GO:0019227) | 3.20766016 |
| 74 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.20757118 |
| 75 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.20271340 |
| 76 | creatine metabolic process (GO:0006600) | 3.18516958 |
| 77 | cell communication by electrical coupling (GO:0010644) | 3.17472417 |
| 78 | response to auditory stimulus (GO:0010996) | 3.16763655 |
| 79 | muscle contraction (GO:0006936) | 3.15412127 |
| 80 | behavioral response to nicotine (GO:0035095) | 3.14722157 |
| 81 | organelle transport along microtubule (GO:0072384) | 3.14498358 |
| 82 | clathrin coat assembly (GO:0048268) | 3.13966470 |
| 83 | synapse assembly (GO:0007416) | 3.12975346 |
| 84 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.11277997 |
| 85 | long-term memory (GO:0007616) | 3.10927901 |
| 86 | myotube cell development (GO:0014904) | 3.10706433 |
| 87 | cerebellar granule cell differentiation (GO:0021707) | 3.09973592 |
| 88 | prepulse inhibition (GO:0060134) | 3.07444289 |
| 89 | positive regulation of membrane potential (GO:0045838) | 3.06472942 |
| 90 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.05637640 |
| 91 | positive regulation of mitochondrial fission (GO:0090141) | 3.03530552 |
| 92 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.03201923 |
| 93 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.03188849 |
| 94 | regulation of postsynaptic membrane potential (GO:0060078) | 3.01460331 |
| 95 | response to muscle activity (GO:0014850) | 3.01334636 |
| 96 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.00996003 |
| 97 | cellular potassium ion homeostasis (GO:0030007) | 3.00386959 |
| 98 | presynaptic membrane organization (GO:0097090) | 3.00102113 |
| 99 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.99736333 |
| 100 | neuron projection extension (GO:1990138) | 2.99639120 |
| 101 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.99302360 |
| 102 | synapse organization (GO:0050808) | 2.97228151 |
| 103 | regulation of cell communication by electrical coupling (GO:0010649) | 2.96964408 |
| 104 | synaptic vesicle endocytosis (GO:0048488) | 2.96881117 |
| 105 | innervation (GO:0060384) | 2.96179819 |
| 106 | actomyosin structure organization (GO:0031032) | 2.95673921 |
| 107 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.95139076 |
| 108 | positive regulation of dendritic spine development (GO:0060999) | 2.94980793 |
| 109 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.94875273 |
| 110 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.94179555 |
| 111 | neuromuscular process controlling balance (GO:0050885) | 2.93913407 |
| 112 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.93455552 |
| 113 | regulation of dendritic spine development (GO:0060998) | 2.93367226 |
| 114 | cerebellum development (GO:0021549) | 2.93225150 |
| 115 | regulation of synapse maturation (GO:0090128) | 2.92700853 |
| 116 | establishment of nucleus localization (GO:0040023) | 2.92495408 |
| 117 | transmission of nerve impulse (GO:0019226) | 2.91912738 |
| 118 | synaptic transmission, cholinergic (GO:0007271) | 2.91519613 |
| 119 | dopamine receptor signaling pathway (GO:0007212) | 2.90901229 |
| 120 | membrane depolarization during action potential (GO:0086010) | 2.90817240 |
| 121 | vesicle transport along microtubule (GO:0047496) | 2.90500895 |
| 122 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.89044581 |
| 123 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.89044581 |
| 124 | positive regulation of axon extension (GO:0045773) | 2.88709187 |
| 125 | neurotransmitter transport (GO:0006836) | 2.88058739 |
| 126 | regulation of neurotransmitter secretion (GO:0046928) | 2.86247010 |
| 127 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.85656682 |
| 128 | cardiac muscle hypertrophy (GO:0003300) | 2.83789517 |
| 129 | sodium ion export (GO:0071436) | 2.83473580 |
| 130 | mechanosensory behavior (GO:0007638) | 2.83326089 |
| 131 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.82861537 |
| 132 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.82527170 |
| 133 | positive regulation of synapse assembly (GO:0051965) | 2.82319553 |
| 134 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.81832641 |
| 135 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.81789926 |
| 136 | regulation of synaptic plasticity (GO:0048167) | 2.81125130 |
| 137 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.80969021 |
| 138 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.80914155 |
| 139 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.79503905 |
| 140 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.77899890 |
| 141 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.77899890 |
| 142 | muscle system process (GO:0003012) | 2.77074370 |
| 143 | regulation of sarcomere organization (GO:0060297) | 2.76013049 |
| 144 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.73311300 |
| 145 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.71134984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.79955004 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.40288450 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.95834886 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.92341500 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.85448590 |
| 6 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.65145800 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61884582 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61884582 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.54246166 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.50270660 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.40731567 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.40636082 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39064932 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38767669 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.38289606 |
| 16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.36100327 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.30526210 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.29678511 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26775453 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.21592268 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.20600877 |
| 22 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.18928472 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16052126 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12749216 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.11619266 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.08853564 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.86341201 |
| 28 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.86324974 |
| 29 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.79830920 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.79304959 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.69227475 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68363930 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54302552 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.54250645 |
| 35 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.53738104 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.51985295 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48413518 |
| 38 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.47129936 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45581851 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.45526573 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.44055245 |
| 42 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.42540728 |
| 43 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.41726056 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38969907 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36277337 |
| 46 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32118479 |
| 47 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30596930 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29789643 |
| 49 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.27235382 |
| 50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26909577 |
| 51 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.26602909 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26444198 |
| 53 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26278121 |
| 54 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26277218 |
| 55 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.25026937 |
| 56 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.24988592 |
| 57 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24337506 |
| 58 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.24261990 |
| 59 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.23340724 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22184291 |
| 61 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21839486 |
| 62 | VDR_22108803_ChIP-Seq_LS180_Human | 1.21211973 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21183694 |
| 64 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.21100001 |
| 65 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20983294 |
| 66 | * AR_19668381_ChIP-Seq_PC3_Human | 1.20213669 |
| 67 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.19056982 |
| 68 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.17692085 |
| 69 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16923729 |
| 70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15337085 |
| 71 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.14327352 |
| 72 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14312848 |
| 73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13559900 |
| 74 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.12633910 |
| 75 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.12203997 |
| 76 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.12166194 |
| 77 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.11386988 |
| 78 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.10458977 |
| 79 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.09855898 |
| 80 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09669368 |
| 81 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08940590 |
| 82 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07822462 |
| 83 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07454816 |
| 84 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06821604 |
| 85 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04691985 |
| 86 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01865276 |
| 87 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01777036 |
| 88 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01777036 |
| 89 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01508178 |
| 90 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00846350 |
| 91 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00254223 |
| 92 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99235912 |
| 93 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98812457 |
| 94 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98812457 |
| 95 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98725029 |
| 96 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98258227 |
| 97 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97969568 |
| 98 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.97656510 |
| 99 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97209797 |
| 100 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97029989 |
| 101 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96855874 |
| 102 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96850447 |
| 103 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96548830 |
| 104 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.95000127 |
| 105 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.94280851 |
| 106 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.94124183 |
| 107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94090451 |
| 108 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93928654 |
| 109 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.92945515 |
| 110 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92358911 |
| 111 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 0.92126551 |
| 112 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92088125 |
| 113 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91519984 |
| 114 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90960760 |
| 115 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90505422 |
| 116 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90504786 |
| 117 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90273108 |
| 118 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.90240213 |
| 119 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90206373 |
| 120 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89251438 |
| 121 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.89090976 |
| 122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88553908 |
| 123 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.86907816 |
| 124 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85955254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.65821774 |
| 2 | MP0004270_analgesia | 3.95392822 |
| 3 | MP0003880_abnormal_central_pattern | 3.78488742 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.70589504 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.09256021 |
| 6 | MP0005423_abnormal_somatic_nervous | 3.04290237 |
| 7 | MP0009745_abnormal_behavioral_response | 2.77217861 |
| 8 | MP0002734_abnormal_mechanical_nocicepti | 2.66323694 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.49679134 |
| 10 | MP0002064_seizures | 2.45535549 |
| 11 | MP0000778_abnormal_nervous_system | 2.44769894 |
| 12 | MP0000751_myopathy | 2.40877074 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.39903927 |
| 14 | MP0009046_muscle_twitch | 2.37179736 |
| 15 | MP0004145_abnormal_muscle_electrophysio | 2.35487919 |
| 16 | MP0001486_abnormal_startle_reflex | 2.25697275 |
| 17 | MP0002184_abnormal_innervation | 2.12069717 |
| 18 | MP0001984_abnormal_olfaction | 2.10174613 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.07842946 |
| 20 | MP0002733_abnormal_thermal_nociception | 1.99487392 |
| 21 | MP0001440_abnormal_grooming_behavior | 1.99315136 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.99010007 |
| 23 | MP0002272_abnormal_nervous_system | 1.95637310 |
| 24 | MP0006276_abnormal_autonomic_nervous | 1.95326131 |
| 25 | MP0002332_abnormal_exercise_endurance | 1.88491869 |
| 26 | MP0004811_abnormal_neuron_physiology | 1.85600808 |
| 27 | MP0002736_abnormal_nociception_after | 1.81650350 |
| 28 | MP0000750_abnormal_muscle_regeneration | 1.81623666 |
| 29 | MP0005386_behavior/neurological_phenoty | 1.80724400 |
| 30 | MP0004924_abnormal_behavior | 1.80724400 |
| 31 | MP0002067_abnormal_sensory_capabilities | 1.80537168 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.79201788 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.79105057 |
| 34 | MP0004858_abnormal_nervous_system | 1.77647486 |
| 35 | MP0003329_amyloid_beta_deposits | 1.75366807 |
| 36 | MP0001970_abnormal_pain_threshold | 1.74606116 |
| 37 | MP0003646_muscle_fatigue | 1.70085292 |
| 38 | MP0000955_abnormal_spinal_cord | 1.64992581 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.64781614 |
| 40 | MP0008569_lethality_at_weaning | 1.61642063 |
| 41 | MP0002822_catalepsy | 1.60790705 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.50703644 |
| 43 | MP0001529_abnormal_vocalization | 1.49589410 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.48129950 |
| 45 | MP0004215_abnormal_myocardial_fiber | 1.47804577 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.43700859 |
| 47 | MP0002066_abnormal_motor_capabilities/c | 1.37562420 |
| 48 | MP0004130_abnormal_muscle_cell | 1.35468840 |
| 49 | MP0002102_abnormal_ear_morphology | 1.32997231 |
| 50 | MP0003121_genomic_imprinting | 1.30820147 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.30787137 |
| 52 | MP0004233_abnormal_muscle_weight | 1.29115066 |
| 53 | MP0005330_cardiomyopathy | 1.28865230 |
| 54 | MP0003137_abnormal_impulse_conducting | 1.27160115 |
| 55 | MP0004885_abnormal_endolymph | 1.24354418 |
| 56 | MP0002152_abnormal_brain_morphology | 1.23534481 |
| 57 | MP0003879_abnormal_hair_cell | 1.17445454 |
| 58 | MP0005620_abnormal_muscle_contractility | 1.16530255 |
| 59 | MP0003122_maternal_imprinting | 1.15310740 |
| 60 | MP0000749_muscle_degeneration | 1.15256951 |
| 61 | MP0000747_muscle_weakness | 1.14372766 |
| 62 | MP0004036_abnormal_muscle_relaxation | 1.10465154 |
| 63 | MP0004085_abnormal_heartbeat | 1.09965870 |
| 64 | MP0002106_abnormal_muscle_physiology | 1.09859149 |
| 65 | MP0005187_abnormal_penis_morphology | 1.08178293 |
| 66 | MP0005646_abnormal_pituitary_gland | 1.06946351 |
| 67 | MP0001502_abnormal_circadian_rhythm | 1.05808053 |
| 68 | MP0004510_myositis | 1.05318752 |
| 69 | MP0004142_abnormal_muscle_tone | 1.00988859 |
| 70 | MP0005499_abnormal_olfactory_system | 1.00942451 |
| 71 | MP0005394_taste/olfaction_phenotype | 1.00942451 |
| 72 | MP0003787_abnormal_imprinting | 1.00324956 |
| 73 | MP0004484_altered_response_of | 0.99878170 |
| 74 | MP0001905_abnormal_dopamine_level | 0.98211338 |
| 75 | MP0000759_abnormal_skeletal_muscle | 0.97823153 |
| 76 | MP0003633_abnormal_nervous_system | 0.97284040 |
| 77 | MP0002127_abnormal_cardiovascular_syste | 0.95414248 |
| 78 | MP0004087_abnormal_muscle_fiber | 0.94511837 |
| 79 | MP0008961_abnormal_basal_metabolism | 0.93019818 |
| 80 | MP0005369_muscle_phenotype | 0.92256504 |
| 81 | MP0000631_abnormal_neuroendocrine_gland | 0.91788816 |
| 82 | MP0001544_abnormal_cardiovascular_syste | 0.88905951 |
| 83 | MP0005385_cardiovascular_system_phenoty | 0.88905951 |
| 84 | MP0001188_hyperpigmentation | 0.88740122 |
| 85 | MP0002752_abnormal_somatic_nervous | 0.88061834 |
| 86 | MP0003634_abnormal_glial_cell | 0.87947527 |
| 87 | MP0001299_abnormal_eye_distance/ | 0.86397045 |
| 88 | MP0002069_abnormal_eating/drinking_beha | 0.86188817 |
| 89 | MP0003861_abnormal_nervous_system | 0.84850540 |
| 90 | MP0004742_abnormal_vestibular_system | 0.84304987 |
| 91 | MP0003631_nervous_system_phenotype | 0.84230040 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 0.83497610 |
| 93 | MP0000733_abnormal_muscle_development | 0.83227043 |
| 94 | MP0005266_abnormal_metabolism | 0.82870312 |
| 95 | MP0000013_abnormal_adipose_tissue | 0.81721996 |
| 96 | MP0004084_abnormal_cardiac_muscle | 0.79000169 |
| 97 | MP0008789_abnormal_olfactory_epithelium | 0.78964302 |
| 98 | MP0002229_neurodegeneration | 0.77372509 |
| 99 | MP0002108_abnormal_muscle_morphology | 0.77154640 |
| 100 | MP0002972_abnormal_cardiac_muscle | 0.76930623 |
| 101 | MP0001348_abnormal_lacrimal_gland | 0.76789315 |
| 102 | MP0002234_abnormal_pharynx_morphology | 0.73444120 |
| 103 | MP0010630_abnormal_cardiac_muscle | 0.72579405 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 0.72571196 |
| 105 | MP0002269_muscular_atrophy | 0.69756197 |
| 106 | MP0008775_abnormal_heart_ventricle | 0.69250171 |
| 107 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69045682 |
| 108 | MP0002638_abnormal_pupillary_reflex | 0.68094999 |
| 109 | MP0006138_congestive_heart_failure | 0.67901953 |
| 110 | MP0006072_abnormal_retinal_apoptosis | 0.67011930 |
| 111 | MP0005535_abnormal_body_temperature | 0.63203540 |
| 112 | MP0010386_abnormal_urinary_bladder | 0.63142585 |
| 113 | MP0002090_abnormal_vision | 0.63080189 |
| 114 | MP0005623_abnormal_meninges_morphology | 0.62208213 |
| 115 | MP0004133_heterotaxia | 0.62080860 |
| 116 | MP0001963_abnormal_hearing_physiology | 0.60898830 |
| 117 | MP0001943_abnormal_respiration | 0.60888900 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.94958075 |
| 2 | Myokymia (HP:0002411) | 4.70221768 |
| 3 | Visual hallucinations (HP:0002367) | 4.49830156 |
| 4 | Focal seizures (HP:0007359) | 4.22323646 |
| 5 | Mutism (HP:0002300) | 3.94667717 |
| 6 | Exercise-induced myalgia (HP:0003738) | 3.86749087 |
| 7 | Muscle fiber splitting (HP:0003555) | 3.81022882 |
| 8 | Epileptic encephalopathy (HP:0200134) | 3.68438012 |
| 9 | Subaortic stenosis (HP:0001682) | 3.53649777 |
| 10 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.53649777 |
| 11 | Ankle clonus (HP:0011448) | 3.52317018 |
| 12 | Broad-based gait (HP:0002136) | 3.51830596 |
| 13 | Myoglobinuria (HP:0002913) | 3.46764006 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 3.45173295 |
| 15 | Round ear (HP:0100830) | 3.45171997 |
| 16 | Limb dystonia (HP:0002451) | 3.27924022 |
| 17 | Calcaneovalgus deformity (HP:0001848) | 3.26581742 |
| 18 | Frequent falls (HP:0002359) | 3.24950341 |
| 19 | Amyotrophic lateral sclerosis (HP:0007354) | 3.18307463 |
| 20 | Fetal akinesia sequence (HP:0001989) | 3.16793038 |
| 21 | Absence seizures (HP:0002121) | 3.16528173 |
| 22 | Progressive cerebellar ataxia (HP:0002073) | 3.11723757 |
| 23 | Poor eye contact (HP:0000817) | 3.09642208 |
| 24 | Supranuclear gaze palsy (HP:0000605) | 3.08733231 |
| 25 | Atonic seizures (HP:0010819) | 3.04923400 |
| 26 | Neck muscle weakness (HP:0000467) | 3.03260204 |
| 27 | Muscle fiber inclusion bodies (HP:0100299) | 2.99727349 |
| 28 | Rhabdomyolysis (HP:0003201) | 2.99197896 |
| 29 | Ulnar deviation of the wrist (HP:0003049) | 2.98887542 |
| 30 | Urinary urgency (HP:0000012) | 2.96963763 |
| 31 | Febrile seizures (HP:0002373) | 2.96784364 |
| 32 | Generalized tonic-clonic seizures (HP:0002069) | 2.96282863 |
| 33 | Deformed tarsal bones (HP:0008119) | 2.93779062 |
| 34 | Abnormality of the corticospinal tract (HP:0002492) | 2.92848792 |
| 35 | Drooling (HP:0002307) | 2.88266494 |
| 36 | Excessive salivation (HP:0003781) | 2.88266494 |
| 37 | Termporal pattern (HP:0011008) | 2.87489709 |
| 38 | Insidious onset (HP:0003587) | 2.87489709 |
| 39 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.87442961 |
| 40 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.86389384 |
| 41 | Progressive inability to walk (HP:0002505) | 2.85719803 |
| 42 | Bundle branch block (HP:0011710) | 2.84282024 |
| 43 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.83790976 |
| 44 | Akinesia (HP:0002304) | 2.82675372 |
| 45 | Action tremor (HP:0002345) | 2.80704507 |
| 46 | Papilledema (HP:0001085) | 2.80243429 |
| 47 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.80228060 |
| 48 | EMG: neuropathic changes (HP:0003445) | 2.77574357 |
| 49 | Dialeptic seizures (HP:0011146) | 2.77114328 |
| 50 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.75473666 |
| 51 | Shoulder girdle muscle weakness (HP:0003547) | 2.74841507 |
| 52 | Absent phalangeal crease (HP:0006109) | 2.72988068 |
| 53 | Hyperventilation (HP:0002883) | 2.71461642 |
| 54 | Impaired social interactions (HP:0000735) | 2.70365030 |
| 55 | Abnormal social behavior (HP:0012433) | 2.70365030 |
| 56 | Nemaline bodies (HP:0003798) | 2.67916033 |
| 57 | Calf muscle hypertrophy (HP:0008981) | 2.66610771 |
| 58 | Depression (HP:0000716) | 2.62078994 |
| 59 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.61113091 |
| 60 | Polyphagia (HP:0002591) | 2.59001244 |
| 61 | Pheochromocytoma (HP:0002666) | 2.57933125 |
| 62 | Myotonia (HP:0002486) | 2.56007937 |
| 63 | Sudden death (HP:0001699) | 2.54826437 |
| 64 | Limb-girdle muscle atrophy (HP:0003797) | 2.49606286 |
| 65 | Difficulty running (HP:0009046) | 2.47590884 |
| 66 | Exercise-induced muscle cramps (HP:0003710) | 2.47515692 |
| 67 | Genetic anticipation (HP:0003743) | 2.47328892 |
| 68 | Inappropriate behavior (HP:0000719) | 2.46454699 |
| 69 | Cerebral inclusion bodies (HP:0100314) | 2.44354156 |
| 70 | Truncal ataxia (HP:0002078) | 2.44304554 |
| 71 | Abnormal eating behavior (HP:0100738) | 2.43811197 |
| 72 | Anxiety (HP:0000739) | 2.38904841 |
| 73 | Abnormal finger flexion creases (HP:0006143) | 2.35485040 |
| 74 | Neurofibrillary tangles (HP:0002185) | 2.34280938 |
| 75 | Hypoplasia of the brainstem (HP:0002365) | 2.33319502 |
| 76 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.33319502 |
| 77 | Malignant hyperthermia (HP:0002047) | 2.33155363 |
| 78 | Torticollis (HP:0000473) | 2.32984946 |
| 79 | Amblyopia (HP:0000646) | 2.31395706 |
| 80 | Spastic gait (HP:0002064) | 2.30008786 |
| 81 | Abnormality of the calf musculature (HP:0001430) | 2.29608760 |
| 82 | Lower limb muscle weakness (HP:0007340) | 2.29534992 |
| 83 | Megalencephaly (HP:0001355) | 2.27824335 |
| 84 | Agitation (HP:0000713) | 2.27065219 |
| 85 | Dysdiadochokinesis (HP:0002075) | 2.23928933 |
| 86 | EEG with generalized epileptiform discharges (HP:0011198) | 2.23072317 |
| 87 | Abnormality of the foot musculature (HP:0001436) | 2.22659449 |
| 88 | Lower limb amyotrophy (HP:0007210) | 2.22326904 |
| 89 | Abnormality of the lower motor neuron (HP:0002366) | 2.22300327 |
| 90 | Epileptiform EEG discharges (HP:0011182) | 2.21230036 |
| 91 | Inability to walk (HP:0002540) | 2.20079829 |
| 92 | Neuroendocrine neoplasm (HP:0100634) | 2.17570702 |
| 93 | Areflexia of lower limbs (HP:0002522) | 2.15876520 |
| 94 | Hypsarrhythmia (HP:0002521) | 2.15511865 |
| 95 | Muscle stiffness (HP:0003552) | 2.15288972 |
| 96 | Lissencephaly (HP:0001339) | 2.13587291 |
| 97 | Hemiparesis (HP:0001269) | 2.11334434 |
| 98 | Pachygyria (HP:0001302) | 2.07682599 |
| 99 | Postural instability (HP:0002172) | 2.05453305 |
| 100 | Apathy (HP:0000741) | 2.04944289 |
| 101 | Asymmetric septal hypertrophy (HP:0001670) | 2.04118464 |
| 102 | Generalized muscle weakness (HP:0003324) | 2.03918339 |
| 103 | Focal dystonia (HP:0004373) | 2.03136972 |
| 104 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.02883808 |
| 105 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.02883808 |
| 106 | Diplopia (HP:0000651) | 2.02552451 |
| 107 | Abnormality of binocular vision (HP:0011514) | 2.02552451 |
| 108 | Stereotypic behavior (HP:0000733) | 2.02005213 |
| 109 | Distal lower limb amyotrophy (HP:0008944) | 2.01773375 |
| 110 | Prolonged QT interval (HP:0001657) | 2.01479982 |
| 111 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.01457881 |
| 112 | Scapular winging (HP:0003691) | 2.00064783 |
| 113 | Gaze-evoked nystagmus (HP:0000640) | 2.00021041 |
| 114 | EMG: myopathic abnormalities (HP:0003458) | 1.98131626 |
| 115 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.97625811 |
| 116 | Rimmed vacuoles (HP:0003805) | 1.96581387 |
| 117 | Myopathic facies (HP:0002058) | 1.96384436 |
| 118 | Abnormal EKG (HP:0003115) | 1.95052566 |
| 119 | Pelvic girdle muscle weakness (HP:0003749) | 1.94868296 |
| 120 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.94580014 |
| 121 | Type 1 muscle fiber predominance (HP:0003803) | 1.94307287 |
| 122 | Difficulty climbing stairs (HP:0003551) | 1.94221339 |
| 123 | Increased variability in muscle fiber diameter (HP:0003557) | 1.94044255 |
| 124 | Limb-girdle muscle weakness (HP:0003325) | 1.93959736 |
| 125 | Steppage gait (HP:0003376) | 1.93824382 |
| 126 | Foot dorsiflexor weakness (HP:0009027) | 1.93295974 |
| 127 | Proximal amyotrophy (HP:0007126) | 1.92314426 |
| 128 | Craniofacial dystonia (HP:0012179) | 1.91065148 |
| 129 | Hepatoblastoma (HP:0002884) | 1.90908272 |
| 130 | Ventricular fibrillation (HP:0001663) | 1.90415049 |
| 131 | Dysmetria (HP:0001310) | 1.90211450 |
| 132 | Distal arthrogryposis (HP:0005684) | 1.89837218 |
| 133 | Slender build (HP:0001533) | 1.87752259 |
| 134 | Rapidly progressive (HP:0003678) | 1.86744796 |
| 135 | Gowers sign (HP:0003391) | 1.86705048 |
| 136 | Increased connective tissue (HP:0009025) | 1.85822024 |
| 137 | Failure to thrive in infancy (HP:0001531) | 1.85585255 |
| 138 | Absent speech (HP:0001344) | 1.85255926 |
| 139 | Dilated cardiomyopathy (HP:0001644) | 1.83832414 |
| 140 | Cortical dysplasia (HP:0002539) | 1.83530941 |
| 141 | Distal lower limb muscle weakness (HP:0009053) | 1.81556008 |
| 142 | Ventricular tachycardia (HP:0004756) | 1.80688296 |
| 143 | Gait imbalance (HP:0002141) | 1.80658379 |
| 144 | Left ventricular hypertrophy (HP:0001712) | 1.79827249 |
| 145 | Syncope (HP:0001279) | 1.78207087 |
| 146 | Fatigable weakness (HP:0003473) | 1.76758835 |
| 147 | Abnormality of the neuromuscular junction (HP:0003398) | 1.76758835 |
| 148 | Heart block (HP:0012722) | 1.76620698 |
| 149 | Waddling gait (HP:0002515) | 1.75040387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 6.56236883 |
| 2 | MAP3K9 | 3.32336468 |
| 3 | PHKG1 | 3.25525269 |
| 4 | PHKG2 | 3.25525269 |
| 5 | NTRK3 | 3.07043297 |
| 6 | MAP3K4 | 2.78021155 |
| 7 | MINK1 | 2.70153265 |
| 8 | NTRK2 | 2.35328202 |
| 9 | EPHA4 | 2.28573457 |
| 10 | MAP2K7 | 2.25521098 |
| 11 | PAK6 | 2.06289283 |
| 12 | MAPK13 | 2.04039466 |
| 13 | KSR1 | 1.99087496 |
| 14 | DAPK2 | 1.95980552 |
| 15 | MAP2K4 | 1.84016498 |
| 16 | CASK | 1.83568706 |
| 17 | DYRK2 | 1.75394041 |
| 18 | LATS2 | 1.58791144 |
| 19 | KSR2 | 1.55859408 |
| 20 | CAMKK1 | 1.45110964 |
| 21 | CDK5 | 1.37012904 |
| 22 | TRIM28 | 1.34706535 |
| 23 | MAP3K12 | 1.32639344 |
| 24 | SIK2 | 1.30918811 |
| 25 | OBSCN | 1.30271958 |
| 26 | TNIK | 1.26798659 |
| 27 | EPHA3 | 1.24383820 |
| 28 | PLK2 | 1.21387742 |
| 29 | PAK3 | 1.17851117 |
| 30 | DYRK1B | 1.15688251 |
| 31 | CSNK1G2 | 1.09890219 |
| 32 | LIMK1 | 1.09226142 |
| 33 | NTRK1 | 1.08386460 |
| 34 | UHMK1 | 1.08012447 |
| 35 | TAOK1 | 1.04993453 |
| 36 | PRKD3 | 1.00376536 |
| 37 | PRPF4B | 1.00049098 |
| 38 | DAPK1 | 0.97920279 |
| 39 | PRKCG | 0.97315896 |
| 40 | PNCK | 0.97042302 |
| 41 | NEK1 | 0.93717537 |
| 42 | CDK18 | 0.92314624 |
| 43 | CDK14 | 0.91830223 |
| 44 | GRK5 | 0.91653918 |
| 45 | PIK3CG | 0.90420377 |
| 46 | TYRO3 | 0.89047717 |
| 47 | DYRK1A | 0.88901091 |
| 48 | CDK15 | 0.87212683 |
| 49 | MAPK12 | 0.87036854 |
| 50 | CAMK2G | 0.85008684 |
| 51 | RET | 0.84869141 |
| 52 | CAMK4 | 0.83128975 |
| 53 | DYRK3 | 0.81536434 |
| 54 | MARK2 | 0.80773656 |
| 55 | CAMK2A | 0.80028559 |
| 56 | MAP3K2 | 0.79071044 |
| 57 | CDK19 | 0.78587203 |
| 58 | LMTK2 | 0.76957757 |
| 59 | TTN | 0.76016859 |
| 60 | BCKDK | 0.75873223 |
| 61 | MAP4K2 | 0.75703988 |
| 62 | CDK11A | 0.75236531 |
| 63 | STK11 | 0.74768673 |
| 64 | PDK4 | 0.74600191 |
| 65 | PDK3 | 0.74600191 |
| 66 | PKN1 | 0.74012216 |
| 67 | CAMKK2 | 0.73684624 |
| 68 | MAP3K6 | 0.70371936 |
| 69 | BCR | 0.69823476 |
| 70 | NME1 | 0.69685791 |
| 71 | STK38 | 0.69567956 |
| 72 | CSNK1G1 | 0.65133680 |
| 73 | RPS6KA2 | 0.64150008 |
| 74 | PRKCZ | 0.63170866 |
| 75 | SGK494 | 0.61783344 |
| 76 | SGK223 | 0.61783344 |
| 77 | WNK3 | 0.61272264 |
| 78 | CSNK1G3 | 0.60079775 |
| 79 | SIK3 | 0.58928907 |
| 80 | PRKG1 | 0.58089587 |
| 81 | CAMK2B | 0.57867550 |
| 82 | CCNB1 | 0.57614845 |
| 83 | DMPK | 0.56924310 |
| 84 | MAP2K6 | 0.56724271 |
| 85 | SGK1 | 0.55380243 |
| 86 | EPHB2 | 0.54614636 |
| 87 | SCYL2 | 0.53906104 |
| 88 | PINK1 | 0.53227760 |
| 89 | PRKACA | 0.52357054 |
| 90 | RPS6KA4 | 0.50852627 |
| 91 | SGK3 | 0.50150102 |
| 92 | CAMK1 | 0.47736947 |
| 93 | CAMK1G | 0.46919163 |
| 94 | CSNK1A1L | 0.46095351 |
| 95 | MAPK4 | 0.45892627 |
| 96 | PRKCH | 0.45036110 |
| 97 | PRKAA1 | 0.44226742 |
| 98 | PRKCE | 0.44086628 |
| 99 | MAP3K7 | 0.43814464 |
| 100 | RPS6KA3 | 0.43651264 |
| 101 | FYN | 0.42610796 |
| 102 | SGK2 | 0.42418266 |
| 103 | ICK | 0.42080020 |
| 104 | ALK | 0.42062987 |
| 105 | RAF1 | 0.41750132 |
| 106 | FGFR2 | 0.41561690 |
| 107 | CAMK2D | 0.40648731 |
| 108 | PRKACB | 0.40381529 |
| 109 | TIE1 | 0.40068439 |
| 110 | MAP2K1 | 0.39929469 |
| 111 | ARAF | 0.39656569 |
| 112 | ROCK1 | 0.39515182 |
| 113 | FER | 0.38491890 |
| 114 | FES | 0.37377670 |
| 115 | STK24 | 0.36747261 |
| 116 | MUSK | 0.36745762 |
| 117 | MAPK9 | 0.36355403 |
| 118 | MAP3K5 | 0.35782602 |
| 119 | MAPK10 | 0.34021630 |
| 120 | PIK3CA | 0.31714225 |
| 121 | CSNK1D | 0.30036661 |
| 122 | PRKACG | 0.28966066 |
| 123 | EPHB1 | 0.27800552 |
| 124 | RPS6KB1 | 0.26200822 |
| 125 | TESK1 | 0.24866991 |
| 126 | AKT2 | 0.23509688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.19827922 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 2.78866003 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.74781468 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.47233282 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.46477476 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.40811147 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.23330507 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.22376966 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.21248287 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.11195332 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.99396434 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.96599541 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.91018124 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.89543054 |
| 15 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.89406713 |
| 16 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.78330138 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.73832017 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.70890177 |
| 19 | Axon guidance_Homo sapiens_hsa04360 | 1.68188754 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67575613 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.64142656 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.63610223 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.56380267 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.53246938 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.52424521 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.51603800 |
| 27 | Gap junction_Homo sapiens_hsa04540 | 1.51350103 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.48453451 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.46958101 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44734895 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.40812565 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.38723499 |
| 33 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.34894626 |
| 34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.33700928 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.33430772 |
| 36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.23708995 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.20587591 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.18294346 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16828946 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.13750462 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.13580239 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12647879 |
| 43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.12469032 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12125867 |
| 45 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.11746120 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.07758115 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 1.04436818 |
| 48 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.04147791 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 0.96752234 |
| 50 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.94610710 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93091395 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92023935 |
| 53 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.89872684 |
| 54 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.88982462 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87676756 |
| 56 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87378824 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86053607 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85926242 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83126623 |
| 60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82696736 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.80854309 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80689988 |
| 63 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.80066908 |
| 64 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76594830 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75328178 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74691241 |
| 67 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73936350 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73604670 |
| 69 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73233886 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70602163 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.70435101 |
| 72 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.70343218 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70079805 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69216163 |
| 75 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68069377 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67234661 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66584490 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65153444 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64835234 |
| 80 | Alzheimers disease_Homo sapiens_hsa05010 | 0.64641305 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64271735 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.63932736 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.62364415 |
| 84 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62323407 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61308982 |
| 86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60605926 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60435493 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59763298 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59591686 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58151978 |
| 91 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.57814014 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56997641 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55761662 |
| 94 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.53975655 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53483338 |
| 96 | * Alcoholism_Homo sapiens_hsa05034 | 0.53418928 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51690281 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51578112 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50940377 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50133300 |
| 101 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49391973 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49139130 |
| 103 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48846432 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47334781 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.46753288 |
| 106 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.46376358 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.45599279 |
| 108 | Tight junction_Homo sapiens_hsa04530 | 0.45563821 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44488634 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44414558 |
| 111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42809335 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42395904 |
| 113 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.39827994 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.39238118 |
| 115 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.38079328 |
| 116 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.38019145 |
| 117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.37626029 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33673400 |
| 119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33604021 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33047143 |
| 121 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.32609659 |
| 122 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.31994445 |
| 123 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.31381942 |
| 124 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.31069998 |
| 125 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31009275 |
| 126 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.30599554 |
| 127 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.30440996 |

